1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Monotherapy 1.2.3 Combination Therapy 1.3 Market by Application 1.3.1 Global Neoantigen Targeted Therapies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Medical Research Institution 1.3.3 Hospital and Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Neoantigen Targeted Therapies Market Perspective (2016-2027) 2.2 Neoantigen Targeted Therapies Growth Trends by Regions 2.2.1 Neoantigen Targeted Therapies Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Neoantigen Targeted Therapies Historic Market Share by Regions (2016-2021) 2.2.3 Neoantigen Targeted Therapies Forecasted Market Size by Regions (2022-2027) 2.3 Neoantigen Targeted Therapies Industry Dynamic 2.3.1 Neoantigen Targeted Therapies Market Trends 2.3.2 Neoantigen Targeted Therapies Market Drivers 2.3.3 Neoantigen Targeted Therapies Market Challenges 2.3.4 Neoantigen Targeted Therapies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Neoantigen Targeted Therapies Players by Revenue 3.1.1 Global Top Neoantigen Targeted Therapies Players by Revenue (2016-2021) 3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by Players (2016-2021) 3.2 Global Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Neoantigen Targeted Therapies Revenue 3.4 Global Neoantigen Targeted Therapies Market Concentration Ratio 3.4.1 Global Neoantigen Targeted Therapies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapies Revenue in 2020 3.5 Neoantigen Targeted Therapies Key Players Head office and Area Served 3.6 Key Players Neoantigen Targeted Therapies Product Solution and Service 3.7 Date of Enter into Neoantigen Targeted Therapies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Neoantigen Targeted Therapies Breakdown Data by Type 4.1 Global Neoantigen Targeted Therapies Historic Market Size by Type (2016-2021) 4.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2022-2027) 5 Neoantigen Targeted Therapies Breakdown Data by Application 5.1 Global Neoantigen Targeted Therapies Historic Market Size by Application (2016-2021) 5.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Neoantigen Targeted Therapies Market Size (2016-2027) 6.2 North America Neoantigen Targeted Therapies Market Size by Type 6.2.1 North America Neoantigen Targeted Therapies Market Size by Type (2016-2021) 6.2.2 North America Neoantigen Targeted Therapies Market Size by Type (2022-2027) 6.2.3 North America Neoantigen Targeted Therapies Market Size by Type (2016-2027) 6.3 North America Neoantigen Targeted Therapies Market Size by Application 6.3.1 North America Neoantigen Targeted Therapies Market Size by Application (2016-2021) 6.3.2 North America Neoantigen Targeted Therapies Market Size by Application (2022-2027) 6.3.3 North America Neoantigen Targeted Therapies Market Size by Application (2016-2027) 6.4 North America Neoantigen Targeted Therapies Market Size by Country 6.4.1 North America Neoantigen Targeted Therapies Market Size by Country (2016-2021) 6.4.2 North America Neoantigen Targeted Therapies Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Neoantigen Targeted Therapies Market Size (2016-2027) 7.2 Europe Neoantigen Targeted Therapies Market Size by Type 7.2.1 Europe Neoantigen Targeted Therapies Market Size by Type (2016-2021) 7.2.2 Europe Neoantigen Targeted Therapies Market Size by Type (2022-2027) 7.2.3 Europe Neoantigen Targeted Therapies Market Size by Type (2016-2027) 7.3 Europe Neoantigen Targeted Therapies Market Size by Application 7.3.1 Europe Neoantigen Targeted Therapies Market Size by Application (2016-2021) 7.3.2 Europe Neoantigen Targeted Therapies Market Size by Application (2022-2027) 7.3.3 Europe Neoantigen Targeted Therapies Market Size by Application (2016-2027) 7.4 Europe Neoantigen Targeted Therapies Market Size by Country 7.4.1 Europe Neoantigen Targeted Therapies Market Size by Country (2016-2021) 7.4.2 Europe Neoantigen Targeted Therapies Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Neoantigen Targeted Therapies Market Size (2016-2027) 8.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type 8.2.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2027) 8.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application 8.3.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2027) 8.4 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region 8.4.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Neoantigen Targeted Therapies Market Size (2016-2027) 9.2 Latin America Neoantigen Targeted Therapies Market Size by Type 9.2.1 Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2021) 9.2.2 Latin America Neoantigen Targeted Therapies Market Size by Type (2022-2027) 9.2.3 Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2027) 9.3 Latin America Neoantigen Targeted Therapies Market Size by Application 9.3.1 Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2021) 9.3.2 Latin America Neoantigen Targeted Therapies Market Size by Application (2022-2027) 9.3.3 Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2027) 9.4 Latin America Neoantigen Targeted Therapies Market Size by Country 9.4.1 Latin America Neoantigen Targeted Therapies Market Size by Country (2016-2021) 9.4.2 Latin America Neoantigen Targeted Therapies Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Neoantigen Targeted Therapies Market Size (2016-2027) 10.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type 10.2.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2027) 10.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application 10.3.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2027) 10.4 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country 10.4.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bavarian Nordic 11.1.1 Bavarian Nordic Company Details 11.1.2 Bavarian Nordic Business Overview 11.1.3 Bavarian Nordic Neoantigen Targeted Therapies Introduction 11.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.1.5 Bavarian Nordic Recent Development 11.2 Genocea Biosciences 11.2.1 Genocea Biosciences Company Details 11.2.2 Genocea Biosciences Business Overview 11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Introduction 11.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.2.5 Genocea Biosciences Recent Development 11.3 Gradalis 11.3.1 Gradalis Company Details 11.3.2 Gradalis Business Overview 11.3.3 Gradalis Neoantigen Targeted Therapies Introduction 11.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.3.5 Gradalis Recent Development 11.4 Immunicum 11.4.1 Immunicum Company Details 11.4.2 Immunicum Business Overview 11.4.3 Immunicum Neoantigen Targeted Therapies Introduction 11.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.4.5 Immunicum Recent Development 11.5 Immunovative Therapies 11.5.1 Immunovative Therapies Company Details 11.5.2 Immunovative Therapies Business Overview 11.5.3 Immunovative Therapies Neoantigen Targeted Therapies Introduction 11.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.5.5 Immunovative Therapies Recent Development 11.6 Iovance Biotherapeutics 11.6.1 Iovance Biotherapeutics Company Details 11.6.2 Iovance Biotherapeutics Business Overview 11.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Introduction 11.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.6.5 Iovance Biotherapeutics Recent Development 11.7 MediGene 11.7.1 MediGene Company Details 11.7.2 MediGene Business Overview 11.7.3 MediGene Neoantigen Targeted Therapies Introduction 11.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.7.5 MediGene Recent Development 11.8 Neon Therapeutics 11.8.1 Neon Therapeutics Company Details 11.8.2 Neon Therapeutics Business Overview 11.8.3 Neon Therapeutics Neoantigen Targeted Therapies Introduction 11.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021) 11.8.5 Neon Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Neoantigen Targeted Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Monotherapy Table 3. Key Players of Combination Therapy Table 4. Global Neoantigen Targeted Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Neoantigen Targeted Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Neoantigen Targeted Therapies Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Neoantigen Targeted Therapies Market Share by Regions (2016-2021) Table 8. Global Neoantigen Targeted Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Neoantigen Targeted Therapies Market Share by Regions (2022-2027) Table 10. Neoantigen Targeted Therapies Market Trends Table 11. Neoantigen Targeted Therapies Market Drivers Table 12. Neoantigen Targeted Therapies Market Challenges Table 13. Neoantigen Targeted Therapies Market Restraints Table 14. Global Neoantigen Targeted Therapies Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Neoantigen Targeted Therapies Market Share by Players (2016-2021) Table 16. Global Top Neoantigen Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neoantigen Targeted Therapies as of 2020) Table 17. Ranking of Global Top Neoantigen Targeted Therapies Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapies Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Neoantigen Targeted Therapies Product Solution and Service Table 21. Date of Enter into Neoantigen Targeted Therapies Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million) Table 24. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2016-2021) Table 25. Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Neoantigen Targeted Therapies Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Neoantigen Targeted Therapies Revenue Market Share by Application (2016-2021) Table 29. Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Neoantigen Targeted Therapies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million) Table 32. North America Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million) Table 34. North America Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million) Table 61. Bavarian Nordic Company Details Table 62. Bavarian Nordic Business Overview Table 63. Bavarian Nordic Neoantigen Targeted Therapies Product Table 64. Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 65. Bavarian Nordic Recent Development Table 66. Genocea Biosciences Company Details Table 67. Genocea Biosciences Business Overview Table 68. Genocea Biosciences Neoantigen Targeted Therapies Product Table 69. Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 70. Genocea Biosciences Recent Development Table 71. Gradalis Company Details Table 72. Gradalis Business Overview Table 73. Gradalis Neoantigen Targeted Therapies Product Table 74. Gradalis Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 75. Gradalis Recent Development Table 76. Immunicum Company Details Table 77. Immunicum Business Overview Table 78. Immunicum Neoantigen Targeted Therapies Product Table 79. Immunicum Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 80. Immunicum Recent Development Table 81. Immunovative Therapies Company Details Table 82. Immunovative Therapies Business Overview Table 83. Immunovative Therapies Neoantigen Targeted Therapies Product Table 84. Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 85. Immunovative Therapies Recent Development Table 86. Iovance Biotherapeutics Company Details Table 87. Iovance Biotherapeutics Business Overview Table 88. Iovance Biotherapeutics Neoantigen Targeted Therapies Product Table 89. Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 90. Iovance Biotherapeutics Recent Development Table 91. MediGene Company Details Table 92. MediGene Business Overview Table 93. MediGene Neoantigen Targeted Therapies Product Table 94. MediGene Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 95. MediGene Recent Development Table 96. Neon Therapeutics Company Details Table 97. Neon Therapeutics Business Overview Table 98. Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million) Table 99. Neon Therapeutics Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Neoantigen Targeted Therapies Market Share by Type: 2020 VS 2027 Figure 2. Monotherapy Features Figure 3. Combination Therapy Features Figure 4. Global Neoantigen Targeted Therapies Market Share by Application: 2020 VS 2027 Figure 5. Medical Research Institution Case Studies Figure 6. Hospital and Clinic Case Studies Figure 7. Other Case Studies Figure 8. Neoantigen Targeted Therapies Report Years Considered Figure 9. Global Neoantigen Targeted Therapies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Neoantigen Targeted Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Neoantigen Targeted Therapies Market Share by Regions: 2020 VS 2027 Figure 12. Global Neoantigen Targeted Therapies Market Share by Regions (2022-2027) Figure 13. Global Neoantigen Targeted Therapies Market Share by Players in 2020 Figure 14. Global Top Neoantigen Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neoantigen Targeted Therapies as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapies Revenue in 2020 Figure 16. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2016-2021) Figure 17. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2022-2027) Figure 18. North America Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Neoantigen Targeted Therapies Market Share by Type (2016-2027) Figure 20. North America Neoantigen Targeted Therapies Market Share by Application (2016-2027) Figure 21. North America Neoantigen Targeted Therapies Market Share by Country (2016-2027) Figure 22. United States Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Neoantigen Targeted Therapies Market Share by Type (2016-2027) Figure 26. Europe Neoantigen Targeted Therapies Market Share by Application (2016-2027) Figure 27. Europe Neoantigen Targeted Therapies Market Share by Country (2016-2027) Figure 28. Germany Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Neoantigen Targeted Therapies Market Share by Type (2016-2027) Figure 36. Asia-Pacific Neoantigen Targeted Therapies Market Share by Application (2016-2027) Figure 37. Asia-Pacific Neoantigen Targeted Therapies Market Share by Region (2016-2027) Figure 38. China Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Neoantigen Targeted Therapies Market Share by Type (2016-2027) Figure 46. Latin America Neoantigen Targeted Therapies Market Share by Application (2016-2027) Figure 47. Latin America Neoantigen Targeted Therapies Market Share by Country (2016-2027) Figure 48. Mexico Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Neoantigen Targeted Therapies Market Share by Type (2016-2027) Figure 52. Middle East & Africa Neoantigen Targeted Therapies Market Share by Application (2016-2027) Figure 53. Middle East & Africa Neoantigen Targeted Therapies Market Share by Country (2016-2027) Figure 54. Turkey Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Bavarian Nordic Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 58. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 59. Gradalis Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 60. Immunicum Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 61. Immunovative Therapies Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 62. Iovance Biotherapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 63. MediGene Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 64. Neon Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Bavarian Nordic Genocea Biosciences Gradalis Immunicum Immunovative Therapies Iovance Biotherapeutics MediGene Neon Therapeutics